From: Tazia Smith
Sent: 4/22/2014 4:16:17 PM
To: jeevacatio
CC: Paul ' Vahe Stepanian
Vinit Sahni
Subject: Re: Biotech Update... Gilead beat, shares halted (CJ
Classification: Confidential
Jeffrey - sure you see this, just making sure, Gilead shares are halted in the after-market following a significant top and
bottom-line earnings beat ($1.48 vs $0.92 cons eps, 55bn on the topline vs. expecations of 53.96bn) as you know, you're
long 8100 shares at an average price of $79.41, stock closed today at $72.86, just reported.
Shares expected to re-open at 4:30pm
GILD US $
At 16:00 Pz- tiv 71.60 morl.e ...- 72./36 / 72 .8 -
SI Save As 141 Acti ons . Indit - 6$ Table Une that
0:a!!=ilin - or-- - OEM= C,=XIIIIIMII" CS"
77' '7 7 ,1 If • • Max pally v 4 :":" 5. runt .. . 7ttez. 16 E. nt GI
+ Track ., Annotate ,- News ZOOM 85
\ 20
if • Last Price 72.86 / \AV 'P. kit v‘li 1
T High on 02/25/14 83.95 ri ri—VI ) 7C
4- Average 66.0548 72.86
4
I Low on 06/21/13 48.83
p g) 65
55
SO
40M
• Volume 23.969M 23,969M
I
t 'Cia2 0
Jun Sep Dec Mar
2013 2014
Froo Tara SmAh clb dbcom
To.
Cc Paul Morris, Va
Date 04/02/2014 03:42 PM
Sub'. — t Biotech Update... CC]
Classification: Confidential
Jeffrey -
Biotech forming a base to some extent (strong market backdrop, clearly) - you're up $906k on your basket excluding the
Ariad (outlier due to M&A prospects vs. group drivers) 1-mo price history charts below.
CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 123735
CONFIDENTIAL SDNY_GM_00269919
EFTA01461593